Lucid Diagnostics Inc. (LUCD) has a negative trailing P/E of -2.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -50.09%.
Criteria proven by this page:
Overall SharesGrow Score: 43/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2018 | -386.3 | 0.00 | -409.37 | 0.00 | - |
| 2019 | -98.4 | -0.33 | -81.94 | 0.00 | - |
| 2020 | -52.5 | -0.63 | -32.18 | 0.00 | - |
| 2021 | -6.9 | -0.03 | 3.54 | 387.26 | - |
| 2022 | -0.9 | -0.01 | 2.13 | 130.49 | - |
| 2023 | -1.1 | 0.06 | -25.48 | 24.25 | - |
| 2024 | -0.9 | 0.05 | 7.67 | 9.52 | - |
| 2025 | -1.9 | 0.06 | 10.16 | 23.61 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2018 | $-0.03 | $0.00 | $-1.13M | - |
| 2019 | $-0.12 | $0.00 | $-4.42M | - |
| 2020 | $-0.22 | $0.00 | $-8.28M | - |
| 2021 | $-1.51 | $500K | $-28.08M | -5615.6% |
| 2022 | $-1.55 | $377K | $-56.17M | -14899.5% |
| 2023 | $-1.26 | $2.43M | $-52.67M | -2169.1% |
| 2024 | $-1.05 | $4.35M | $-45.53M | -1047.6% |
| 2025 | $-0.69 | $4.71M | $-58.01M | -1232.7% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.25 | $-0.36 – $-0.17 | $10.93M | $8.3M – $14.8M | 2 |
| 2027 | $-0.19 | $-0.19 – $-0.18 | $24.91M | $14.74M – $39.99M | 3 |
| 2028 | $-0.16 | $-0.23 – $-0.11 | $28.7M | $21.78M – $38.87M | 1 |
| 2029 | $-0.13 | $-0.19 – $-0.09 | $42M | $31.88M – $56.89M | 1 |
| 2030 | $-0.09 | $-0.13 – $-0.06 | $58.8M | $44.63M – $79.64M | 1 |
